Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
Sadeghi A, Ali Asgari A, Norouzi A, Kheiri Z, Anushirvani A, Montazeri M, Hosamirudsai H, Afhami S, Akbarpour E, Aliannejad R, Radmard AR, Davarpanah AH, Levi J, Wentzel H, Qavi A, Garratt A, Simmons B, Hill A, Merat S.
Sadeghi A, et al. Among authors: garratt a.
J Antimicrob Chemother. 2020 Nov 1;75(11):3379-3385. doi: 10.1093/jac/dkaa334.
J Antimicrob Chemother. 2020.
PMID: 32812039
Free PMC article.
Clinical Trial.